Response to Letters Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".

scientific article

Response to Letters Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction". is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/CIRCULATIONAHA.115.017050
P932PMC publication ID4653071
P698PubMed publication ID26481572

P50authorMargaret M RedfieldQ98243295
P2093author name stringSelma F Mohammed
P2860cites workCardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.Q34572435
Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fractionQ35072520
Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based studyQ37156991
Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophyQ43781632
Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy?Q82763966
Differences in myocardial structure and coronary microvasculature between men and women with coronary artery diseaseQ82767312
Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney diseaseQ86925701
P433issue16
P407language of work or nameEnglishQ1860
P921main subjectheart failureQ181754
ejection fractionQ641303
Heart failure with preserved ejection fractionQ3799239
P304page(s)e206
P577publication date2015-10-01
P1433published inCirculationQ578091
P1476titleResponse to Letters Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".
P478volume132

Reverse relations

cites work (P2860)
Q52808499Myocardial Effective Transverse Relaxation Time T 2* is Elevated in Hypertrophic Cardiomyopathy: A 7.0 T Magnetic Resonance Imaging Study.
Q51761509Vascular Senescence in Cardiovascular and Metabolic Diseases.

Search more.